Juvenilna Metroragija.
Following the definition and etiology, cases of juvenile bleeding in 66 patients were analysed in connection with the time of its occurrence, its clinical picture and therapy. In the authors' own material the percentage of juvenile bleeding was 4.18. It was noted that juvenile bleeding occurred most frequently in virgins (95.45%), that is in the first three gynecological years (78.79%). The mean value of menarche in juvenile bleeding is 12.7 years. The values of Hb at examination, that is on admission to hospital, illustrate the degree of anemia. There were 38 hospitalized patients, and in 28 patients blod transfusion was applied. The termination of bleeding was achieved by hormone therapy. A successful combination of estrogen-gestagen therapy in the sense of substitution was applied. Only in one case was exploratory curettage performed and this vas due to suspicion of residue following abortion.
D000293:Adolescent; D000367:Age Factors; D002648:Child; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008796:Metrorrhagia / Q000097:blood* / Q000188:drug therapy; D011374:Progesterone / Q000097:blood; D011372:Progestins / Q000627:therapeutic use
D004967:Estrogens; D011372:Progestins; D011374:Progesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone